Search research articles
Contact Us
Filters
Showing results (171-180 of 237) with videos related to
Page
of 24
Sort By:
European Journal of Human Genetics : EJHG
|
May 28, 2015
High prevalence of BRCA1 stop mutation c.4183C>T in the Tyrolean population: implications for genetic testing
Laura Pölsler, Heidi Fiegl, Katharina Wimmer, et al.
Archives of Gynecology and Obstetrics
|
October 16, 2014
Surgical and systemic management of endometrial cancer: an international survey
Christina Fotopoulou, Robert Kraetschell, Sean Dowdy, et al.
Frontiers in Oncology
|
September 26, 2019
Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer-A Study of the GANNET53 Consortium
Isabelle Ray-Coquard, Ioana Braicu, Regina Berger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2005
Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo
Nicole Concin, Gerda Hofstetter, Astrid Berger, et al.
Wiener Medizinische Wochenschrift (1946)
|
October 17, 2015
Prophylactic long-acting granulocyte-colony stimulating factors (G-CSF) in gynecologic malignancies: an oncologic expert statement
Edgar Petru, Christian F Singer, Stephan Polterauer, et al.
Future Oncology (London, England)
|
September 6, 2022
EPIK-O/ENGOT-OV61: alpelisib plus olaparib vs cytotoxic chemotherapy in high-grade serous ovarian cancer (phase III study)
Panagiotis A Konstantinopoulos, Antonio Gonzalez-Martin, Felipe Melo Cruz, et al.
Gynecologic Oncology
|
January 16, 2022
Dubious effects of methadone as an "anticancer" drug on ovarian cancer cell-lines and patient-derived tumor-spheroids
Heidelinde Fiegl, Judith Hagenbuchner, Christiana Kyvelidou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2010
Genomic index of sensitivity to endocrine therapy for breast cancer
W Fraser Symmans, Christos Hatzis, Christos Sotiriou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2011
Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial
Georg Pfeiler, Robert Königsberg, Christian Fesl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 25, 2023
Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - An international pooled analysis of three ESGO accredited centres
Richard Schwameis, Francesco Fanfani, Christoph Ebner, et al.
Page
of 24
Search research articles
Search
Showing results (171-180 of 237) with videos related to
Sort By:
Page
of 24
European Journal of Human Genetics : EJHG
|
May 28, 2015
High prevalence of BRCA1 stop mutation c.4183C>T in the Tyrolean population: implications for genetic testing
Laura Pölsler, Heidi Fiegl, Katharina Wimmer, et al.
Archives of Gynecology and Obstetrics
|
October 16, 2014
Surgical and systemic management of endometrial cancer: an international survey
Christina Fotopoulou, Robert Kraetschell, Sean Dowdy, et al.
Frontiers in Oncology
|
September 26, 2019
Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer-A Study of the GANNET53 Consortium
Isabelle Ray-Coquard, Ioana Braicu, Regina Berger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2005
Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo
Nicole Concin, Gerda Hofstetter, Astrid Berger, et al.
Wiener Medizinische Wochenschrift (1946)
|
October 17, 2015
Prophylactic long-acting granulocyte-colony stimulating factors (G-CSF) in gynecologic malignancies: an oncologic expert statement
Edgar Petru, Christian F Singer, Stephan Polterauer, et al.
Future Oncology (London, England)
|
September 6, 2022
EPIK-O/ENGOT-OV61: alpelisib plus olaparib vs cytotoxic chemotherapy in high-grade serous ovarian cancer (phase III study)
Panagiotis A Konstantinopoulos, Antonio Gonzalez-Martin, Felipe Melo Cruz, et al.
Gynecologic Oncology
|
January 16, 2022
Dubious effects of methadone as an "anticancer" drug on ovarian cancer cell-lines and patient-derived tumor-spheroids
Heidelinde Fiegl, Judith Hagenbuchner, Christiana Kyvelidou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2010
Genomic index of sensitivity to endocrine therapy for breast cancer
W Fraser Symmans, Christos Hatzis, Christos Sotiriou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2011
Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial
Georg Pfeiler, Robert Königsberg, Christian Fesl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 25, 2023
Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - An international pooled analysis of three ESGO accredited centres
Richard Schwameis, Francesco Fanfani, Christoph Ebner, et al.
Page
of 24